Linked Life Data

19601688

Source:http://linkedlifedata.com/resource/pubmed/id/19601688

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5 Suppl
pubmed:dateCreated
2009-7-15
pubmed:abstractText
Although symptoms of attention-deficit/ hyperactivity disorder (ADHD) are certainly most visible in children, the syndrome persists into adolescence in 40% to 70% of cases and into adulthood in 50% or more of cases. Accurate recognition of the disorder is clouded by the frequent presence of psychiatric comorbidities. Contributing to these challenges, managed care providers in primary care are often inexperienced in identifying and treating ADHD in adults because of a lack of formalized training. As such, special consideration must be given to each individual age group and includes identifying common clinical presentations, characterizing the disorder and its comorbidities, applying validated rating scales as screening and treatment outcome measures, and individually assessing patients' optimal response to determine the best course of therapy. Pharmacotherapy is often initiated to target ADHD symptoms with either a stimulant medication or nonstimulants. In addition, behavioral interventions are often applied to treat comorbidities and associated impairments of ADHD.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
H
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1936-2692
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S129-40
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
pubmed:affiliation
The REACH Institute, 450 Seventh Ave, Ste 1107, New York, NY 10123, USA. peter.jensen@thereachinstitute.org
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't